virus
-

Details emerge of first Huntingtonâs disease gene therapy clinical trial
UniQure announces key details of its planned trial to assess the safety and ability of AMT-130 gene therapy to lower the problematic huntingtin protein using a âsingle-shotâ virus delivery system.

